Home/Filings/4/0001209191-22-007325
4//SEC Filing

Bernstein Karen 4

Accession 0001209191-22-007325

CIK 0001636651other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 8:47 PM ET

Size

5.3 KB

Accession

0001209191-22-007325

Insider Transaction Report

Form 4
Period: 2022-02-03
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-03+15,00015,000 total
    Exercise: $2.72Exp: 2032-02-02Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001654055

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:47 PM ET
Size
5.3 KB